Literature DB >> 19944458

The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells.

Sharan Ramaswamy1, Danielle Gottlieb, George C Engelmayr, Elena Aikawa, David E Schmidt, Diana M Gaitan-Leon, Virna L Sales, John E Mayer, Michael S Sacks.   

Abstract

We have previously shown that combined flexure and flow (CFF) augment engineered heart valve tissue formation using bone marrow-derived mesenchymal stem cells (MSC) seeded on polyglycolic acid (PGA)/poly-L-lactic acid (PLLA) blend nonwoven fibrous scaffolds (Engelmayr, et al., Biomaterials 2006; vol. 27 pp. 6083-95). In the present study, we sought to determine if these phenomena were reproducible at the organ level in a functional tri-leaflet valve. Tissue engineered valve constructs (TEVC) were fabricated using PGA/PLLA nonwoven fibrous scaffolds then seeded with MSCs. Tissue formation rates using both standard and augmented (using basic fibroblast growth factor [bFGF] and ascorbic acid-2-phosphate [AA2P]) media to enhance the overall production of collagen were evaluated, along with their relation to the local fluid flow fields. The resulting TEVCs were statically cultured for 3 weeks, followed by a 3 week dynamic culture period using our organ level bioreactor (Hildebrand et al., ABME, Vol. 32, pp. 1039-49, 2004) under approximated pulmonary artery conditions. Results indicated that supplemented media accelerated collagen formation (approximately 185% increase in collagen mass/MSC compared to standard media), as well as increasing collagen mass production from 3.90 to 4.43 pg/cell/week from 3 to 6 weeks. Using augmented media, dynamic conditioning increased collagen mass production rate from 7.23 to 13.65 pg/cell/week (88.8%) during the dynamic culture period, along with greater preservation of net DNA. Moreover, when compared to our previous CFF study, organ level conditioning increased the collagen production rate from 4.76 to 6.42 pg/cell/week (35%). Newly conducted CFD studies of the CFF specimen flow patterns suggested that oscillatory surface shear stresses were surprisingly similar to a tri-leaflet valve. Overall, we found that the use of simulated pulmonary artery conditions resulted in substantially larger collagen mass production levels and rates found in our earlier CFF study. Moreover, given the fact that the scaffolds underwent modest strains (approximately 7% max) during either CFF or physiological conditioning, the oscillatory surface shear stresses estimated in both studies may play a substantial role in eliciting MSC collagen production in the highly dynamic engineered heart valve fluid mechanical environment. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19944458      PMCID: PMC2813971          DOI: 10.1016/j.biomaterials.2009.10.019

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  46 in total

1.  Functional living trileaflet heart valves grown in vitro.

Authors:  S P Hoerstrup; R Sodian; S Daebritz; J Wang; E A Bacha; D P Martin; A M Moran; K J Guleserian; J S Sperling; S Kaushal; J P Vacanti; F J Schoen; J E Mayer
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

2.  Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway.

Authors:  Craig A Simmons; Sean Matlis; Amanda J Thornton; Shaoqiong Chen; Cun Yu Wang; David J Mooney
Journal:  J Biomech       Date:  2003-08       Impact factor: 2.712

Review 3.  Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling.

Authors:  Lisa E Freed; Farshid Guilak; X Edward Guo; Martha L Gray; Robert Tranquillo; Jeffrey W Holmes; Milica Radisic; Michael V Sefton; David Kaplan; Gordana Vunjak-Novakovic
Journal:  Tissue Eng       Date:  2006-12

4.  Prediction of extracellular matrix stiffness in engineered heart valve tissues based on nonwoven scaffolds.

Authors:  George C Engelmayr; Michael S Sacks
Journal:  Biomech Model Mechanobiol       Date:  2007-08-23

5.  Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.

Authors:  Dörthe Schmidt; Josef Achermann; Bernhard Odermatt; Christian Breymann; Anita Mol; Michele Genoni; Gregor Zund; Simon P Hoerstrup
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

6.  A structural model for the flexural mechanics of nonwoven tissue engineering scaffolds.

Authors:  George C Engelmayr; Michael S Sacks
Journal:  J Biomech Eng       Date:  2006-08       Impact factor: 2.097

7.  Chondrogenesis in a cell-polymer-bioreactor system.

Authors:  L E Freed; A P Hollander; I Martin; J R Barry; R Langer; G Vunjak-Novakovic
Journal:  Exp Cell Res       Date:  1998-04-10       Impact factor: 3.905

8.  A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications.

Authors:  Thomas C Flanagan; Brendan Wilkins; Alexander Black; Stefan Jockenhoevel; Terence J Smith; Abhay S Pandit
Journal:  Biomaterials       Date:  2005-11-28       Impact factor: 12.479

9.  Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves.

Authors:  Tjörvi E Perry; Sunjay Kaushal; Fraser W H Sutherland; Kristine J Guleserian; Joyce Bischoff; Michael Sacks; John E Mayer
Journal:  Ann Thorac Surg       Date:  2003-03       Impact factor: 4.330

10.  Protein precoating of elastomeric tissue-engineering scaffolds increased cellularity, enhanced extracellular matrix protein production, and differentially regulated the phenotypes of circulating endothelial progenitor cells.

Authors:  Virna L Sales; George C Engelmayr; John A Johnson; Jin Gao; Yadong Wang; Michael S Sacks; John E Mayer
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

View more
  28 in total

Review 1.  EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.

Authors:  M K Sewell-Loftin; Young Wook Chun; Ali Khademhosseini; W David Merryman
Journal:  J Cardiovasc Transl Res       Date:  2011-07-13       Impact factor: 4.132

2.  Protocol for relative hydrodynamic assessment of tri-leaflet polymer valves.

Authors:  Sharan Ramaswamy; Manuel Salinas; Rob Carrol; Karla Landaburo; Xavier Ryans; Cynthia Crespo; Ailyn Rivero; Faris Al-Mousily; Curt DeGroff; Mark Bleiweis; Hitomi Yamaguchi
Journal:  J Vis Exp       Date:  2013-10-17       Impact factor: 1.355

3.  A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions.

Authors:  Sharan Ramaswamy; Steven M Boronyak; Trung Le; Andrew Holmes; Fotis Sotiropoulos; Michael S Sacks
Journal:  J Biomech Eng       Date:  2014-12       Impact factor: 2.097

4.  Pediatric tubular pulmonary heart valve from decellularized engineered tissue tubes.

Authors:  Jay M Reimer; Zeeshan H Syedain; Bee H T Haynie; Robert T Tranquillo
Journal:  Biomaterials       Date:  2015-05-16       Impact factor: 12.479

5.  Effect of biodegradation and de novo matrix synthesis on the mechanical properties of valvular interstitial cell-seeded polyglycerol sebacate-polycaprolactone scaffolds.

Authors:  Shilpa Sant; Dharini Iyer; Akhilesh K Gaharwar; Alpesh Patel; Ali Khademhosseini
Journal:  Acta Biomater       Date:  2012-11-17       Impact factor: 8.947

6.  Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering.

Authors:  Nafiseh Masoumi; Aurélie Jean; Jeffrey T Zugates; Katherine L Johnson; George C Engelmayr
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

7.  Three-dimensional extracellular matrix scaffolds by microfluidic fabrication for long-term spontaneously contracted cardiomyocyte culture.

Authors:  Jeng-Chun Mei; Aden Yuan Kun Wu; Po-Chen Wu; Nai-Chen Cheng; Wei-Bor Tsai; Jiashing Yu
Journal:  Tissue Eng Part A       Date:  2014-07-22       Impact factor: 3.845

8.  Modeling the Role of Oscillator Flow and Dynamic Mechanical Conditioning on Dense Connective Tissue Formation in Mesenchymal Stem Cell-Derived Heart Valve Tissue Engineering.

Authors:  João S Soares; Trung B Le; Fotis Sotiropoulos; Michael S Sacks
Journal:  J Med Device       Date:  2013-12-05       Impact factor: 0.582

9.  Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells.

Authors:  B Duan; E Kapetanovic; L A Hockaday; J T Butcher
Journal:  Acta Biomater       Date:  2013-12-12       Impact factor: 8.947

Review 10.  Tissue-engineered heart valve: future of cardiac surgery.

Authors:  Radoslaw A Rippel; Hossein Ghanbari; Alexander M Seifalian
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.